- Home
- RDAC vs CLSD Comparison
RDAC vs CLSD Comparison
Compare RDAC & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDAC
- CLSD
- Stock Information
- Founded
- RDAC 2024
- CLSD 2011
- Country
- RDAC China
- CLSD United States
- Employees
- RDAC N/A
- CLSD N/A
- Industry
- RDAC
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- RDAC
- CLSD Health Care
- Exchange
- RDAC NYSE
- CLSD Nasdaq
- Market Cap
- RDAC 75.2M
- CLSD 81.2M
- IPO Year
- RDAC 2024
- CLSD 2016
- Fundamental
- Price
- RDAC $10.10
- CLSD $0.95
- Analyst Decision
- RDAC
- CLSD Strong Buy
- Analyst Count
- RDAC 0
- CLSD 6
- Target Price
- RDAC N/A
- CLSD $5.33
- AVG Volume (30 Days)
- RDAC 457.0
- CLSD 206.9K
- Earning Date
- RDAC 01-01-0001
- CLSD 03-11-2025
- Dividend Yield
- RDAC N/A
- CLSD N/A
- EPS Growth
- RDAC N/A
- CLSD N/A
- EPS
- RDAC N/A
- CLSD N/A
- Revenue
- RDAC N/A
- CLSD $7,703,000.00
- Revenue This Year
- RDAC N/A
- CLSD N/A
- Revenue Next Year
- RDAC N/A
- CLSD $91.87
- P/E Ratio
- RDAC N/A
- CLSD N/A
- Revenue Growth
- RDAC N/A
- CLSD 248.39
- 52 Week Low
- RDAC $9.98
- CLSD $0.80
- 52 Week High
- RDAC $10.41
- CLSD $2.12
- Technical
- Relative Strength Index (RSI)
- RDAC N/A
- CLSD 43.06
- Support Level
- RDAC N/A
- CLSD $1.00
- Resistance Level
- RDAC N/A
- CLSD $1.09
- Average True Range (ATR)
- RDAC 0.00
- CLSD 0.07
- MACD
- RDAC 0.00
- CLSD -0.01
- Stochastic Oscillator
- RDAC 0.00
- CLSD 16.30
About RDAC RISING DRAGON ACQUISITION CORP
Rising Dragon Acquisition Corp is a blank check company.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.